NCT00541411UnknownNot Applicable
Phase II Pilot Study of Vincristine, Adriamycin, Actinomycin D, Ifosfamide Combination Chemotherapy in Ewing's Sarcoma
King Faisal Specialist Hospital & Research Center0 sites10 target enrollmentStarted: June 1, 2003Last updated:
Conditions
Drugs
Trial Snapshot
- Phase
- Not Applicable
- Enrollment
- 10
- Primary Endpoint
- Efficacy
Study Overview
Brief Summary
Phase II Pilot Study of Vincristine, Adriamycin, Actinomycin D, Ifosfamide combination chemotherapy in Ewing's Sarcoma
Study Design
- Study Type
- Interventional
- Allocation
- Na
- Intervention Model
- Single Group
- Primary Purpose
- Treatment
- Masking
- None
Eligibility Criteria
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Patients with Ewing's Sarcoma
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Efficacy
Time Frame: overall
Secondary Outcomes
No secondary outcomes reported
Investigators
Dr. Naeem A. Chaudhri
Principal Investigator
King Faisal Specialist Hospital & Research Center
Similar Trials
Completed
Phase 3
Combination Chemotherapy in Treating Patients With Previously Untreated RhabdomyosarcomaAdult Malignant MesenchymomaAdult RhabdomyosarcomaAlveolar Childhood RhabdomyosarcomaChildhood Malignant MesenchymomaEmbryonal Childhood RhabdomyosarcomaEmbryonal-botryoid Childhood RhabdomyosarcomaNonmetastatic Childhood Soft Tissue SarcomaPreviously Untreated Childhood RhabdomyosarcomaStage I Adult Soft Tissue SarcomaStage II Adult Soft Tissue SarcomaStage III Adult Soft Tissue SarcomaNCT00003958Children's Oncology Group702
Completed
Phase 3
Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed RhabdomyosarcomaRhabdomyosarcomaAdult RhabdomyosarcomaChildhood Botryoid-Type Embryonal RhabdomyosarcomaStage I Adult Soft Tissue Sarcoma AJCC v7Stage III Adult Soft Tissue Sarcoma AJCC v7Localized Childhood Soft Tissue SarcomaChildhood Alveolar RhabdomyosarcomaChildhood Embryonal RhabdomyosarcomaStage II Adult Soft Tissue Sarcoma AJCC v7SarcomaNCT00354835Children's Oncology Group481
Recruiting
Not Applicable
Phase II study of vincristine, actinomycin-D, cyclophosphamide and irinotecan for patients with newly diagnosed intermediate rhabdomyosarcoma.rhabdomyosarcomaJPRN-UMIN000023956Japan Rhabdomyosarcoma Study Group40
Recruiting
Phase 2
Phase II study of vincristine, actinomycin-D, cyclophosphamide and irinotecan for patients with newly diagnosed low-risk subset B rhabdomyosarcoma.rhabdomyosarcomaJPRN-UMIN000017004Japan Rhabdomyosarcoma Study Group18
Recruiting
Phase 2
Phase II study of VAC1.2/VI therapy for patients with newly diagnosed low-risk subset B rhabdomyosarcoma.D012208rhabdomyosarcomaJPRN-jRCTs051180200Miyachi Mitsuru18